The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases

    December 2011 in “ Advances in Urology ”
    Faris Azzouni, Alejandro Godoy, Yun Li, James L. Mohler
    Studysummary This review discusses the biochemical properties and clinical significance of 5 alpha-reductase isozymes and reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on downloads.hindawi.com →
    Discuss this study in the Community →

    Research cited in this study 20

    1. SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder Cell · 2010
    2. Efficacy, Safety, and Tolerability of Dutasteride 0.5 mg Once Daily in Male Patients with Male Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study Journal of The American Academy of Dermatology · 2010
    3. Male Androgenetic Alopecia Expert Opinion on Pharmacotherapy · 2010
    4. An Overview on 5α-Reductase Inhibitors Steroids · 2009
    5. The Clinical Evaluation of Hirsutism Dermatologic therapy · 2008
    6. Dermatologic Manifestations of Polycystic Ovary Syndrome American Journal of Clinical Dermatology · 2007
    7. The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride Journal of The American Academy of Dermatology · 2006
    8. Dermatology of Androgen-Related Disorders Clinics in Dermatology · 2006
    9. Acne: Hormonal Concepts and Therapy Clinics in Dermatology · 2004
    10. Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 2004
    11. Selective Non-Steroidal Inhibitors of 5α-Reductase Type 1 Journal of steroid biochemistry and molecular biology/˜The œJournal of steroid biochemistry and molecular biology · 2004
    12. An Open, Randomized, Comparative Study of Oral Finasteride and 5% Topical Minoxidil in Male Androgenetic Alopecia Dermatology · 2004
    13. Hair Loss in Women with Hyperandrogenism: Four Cases Responding to Finasteride Journal of The American Academy of Dermatology · 2002
    14. A Comparison of the Relative Efficacy of Antiandrogens for the Treatment of Acne in Hyperandrogenic Women Clinical Endocrinology · 2002
    15. Clinical Application of 5α-Reductase Inhibitors Journal of endocrinological investigation · 2001
    16. New Progesterone Esters as 5α-Reductase Inhibitors Chemical & Pharmaceutical Bulletin · 2001
    17. Comparison of Finasteride Versus Flutamide in the Treatment of Hirsutism European journal of endocrinology · 1999
    18. Immunohistochemical Localization of Types 1 and 2 5α-Reductase in Human Scalp British Journal of Dermatology · 1999
    19. Finasteride in the Treatment of Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1998
    20. The 5 Alpha-Reductase System and Its Inhibitors Dermatology · 1996

    Related research 4

    1. Selective Non-Steroidal Inhibitors of 5α-Reductase Type 1 Journal of steroid biochemistry and molecular biology/˜The œJournal of steroid biochemistry and molecular biology · 2004
    2. Finasteride Inhibits 5α-Reductase Activity in Human Dermal Fibroblasts: Prediction of Its Therapeutic Application in Androgen-Related Skin Diseases International Journal of Dermatology · 1995
    3. Effect of Finasteride, a 5 Alpha-Reductase Inhibitor, on Serum Gonadotropins in Normal Men The Journal of Clinical Endocrinology and Metabolism · 1992
    4. The Clinical Development of a 5α-Reductase Inhibitor, Finasteride The Journal of Steroid Biochemistry and Molecular Biology · 1990